본문으로 건너뛰기
← 뒤로

Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development.

1/5 보강
Frontiers in endocrinology 📖 저널 OA 100% 2021: 2/2 OA 2022: 120/120 OA 2023: 125/125 OA 2024: 102/102 OA 2025: 137/137 OA 2026: 48/48 OA 2021~2026 2022 Vol.13() p. 873027
Retraction 확인
출처

Qu N, Hui Z, Shen Z, Kan C, Hou N, Sun X

📖 무료 전문 🟢 PMC 전문 PMC9114699
📝 환자 설명용 한 줄

Thyroid cancer is the most prevalent endocrine malignancy and the reported incidence of thyroid cancer has continued to increase in recent years.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Qu N, Hui Z, et al. (2022). Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development.. Frontiers in endocrinology, 13, 873027. https://doi.org/10.3389/fendo.2022.873027
MLA Qu N, et al.. "Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development.." Frontiers in endocrinology, vol. 13, 2022, pp. 873027.
PMID 35600591 ↗

Abstract

Thyroid cancer is the most prevalent endocrine malignancy and the reported incidence of thyroid cancer has continued to increase in recent years. Since 2019, coronavirus disease 2019 (COVID-19) has been spreading worldwide in a global pandemic. COVID-19 aggravates primary illnesses and affects disease management; relevant changes include delayed diagnosis and treatment. The thyroid is an endocrine organ that is susceptible to autoimmune attack; thus, thyroid cancer after COVID-19 has gradually attracted attention. Whether COVID-19 affects the diagnosis and treatment of thyroid cancer has also attracted the attention of many researchers. This review examines the literature regarding the influence of COVID-19 on the pathogenesis, diagnosis, and treatment of thyroid cancer; it also focuses on drug therapies to promote research into strategies for improving therapy and management in thyroid cancer patients with COVID-19.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (4)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기